Search Results 371-380 of 18183 for monoclonal antibody

1. Medical Research & Education - Mayo Clinic News Network

   Monoclonal antibody therapy for COVID-19 safe for transplant patients featured image. COVID-19. Monoclonal antibody therapy for COVID-19 safe for transplant ...

2. Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as rituximab, interfere with the ability of cancer cells to grow and spread. It is not yet known whether fludarabine phosphate ...

3. Trastuzumab-pkrb (intravenous route) - Side effects & uses - Mayo Clinic

   Trastuzumab-pkrb is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

4. A Study of Adding AMG 479 to First Line Chemotherapy in Patients with Optimally Debulked Epithelial Ovarian Cancer - Mayo Clinic

   The purpose of this study is to determine the value of adding AMG 479 (a fully human monoclonal antibody against IGF-1R) to paclitaxel and carboplatin ...

5. Atezolizumab In Treating Patients With Recurrent BCG-Unresponsive Non-muscle Invasive Bladder Cancer - Mayo Clinic

   Monoclonal antibodies, such as atezolizumab, may block specific proteins found on white blood cells which may strengthen the immune system and control tumor ...

6. Trastuzumab-qyyp (intravenous route) - Side effects & uses - Mayo Clinic

   Trastuzumab-qyyp is a monoclonal antibody. It interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of ...

7. Anifrolumab-fnia (intravenous route, subcutaneous route) - Side effects & dosage - Mayo Clinic

   It is a monoclonal antibody that changes the immune system to help control lupus symptoms. This medicine is available only with your doctor's prescription ...

8. Nivolumab In Treating Patients With Relapsed Or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

   Monoclonal antibodies, such as nivolumab, may block cancer growth in different ways by targeting certain cells. Participation eligibility. Participant ...

9. Skin Cancer Clinical Trials - Mayo Clinic Research

   Imiquimod may stimulate the immune system. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of tumor cells to grow and spread.

10. Wilms' Tumor Clinical Trials - Mayo Clinic Research

    Monoclonal antibodies, such as cixutumumab, can block tumor growth in different ways. ... Antibody-drug conjugates, such as lorvotuzumab mertansine, are ...